These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14607013)

  • 1. Accessibility of solid core tablet for dissolution in an asymmetric triple-layer matrix system.
    Yang L; Fassihi R
    J Pharm Pharmacol; 2003 Oct; 55(10):1331-7. PubMed ID: 14607013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
    Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A
    J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
    Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New release cell for NMR microimaging of tablets. Swelling and erosion of poly(ethylene oxide).
    Abrahmsén-Alami S; Körner A; Nilsson I; Larsson A
    Int J Pharm; 2007 Sep; 342(1-2):105-14. PubMed ID: 17580107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Per-oral extended-release bioadhesive tablet formulation of verapamil HCl.
    Elkheshen S; Yassin AE; Alkhaled F
    Boll Chim Farm; 2003 Jun; 142(5):226-31. PubMed ID: 14526657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet.
    Timmins P; Delargy AM; Howard JR
    Pharm Dev Technol; 1997 Feb; 2(1):25-31. PubMed ID: 9552428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging.
    Tajiri T; Morita S; Sakamoto R; Suzuki M; Yamanashi S; Ozaki Y; Kitamura S
    Int J Pharm; 2010 Aug; 395(1-2):147-53. PubMed ID: 20580795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study.
    Dahlberg C; Fureby A; Schuleit M; Dvinskikh SV; Furó I
    J Control Release; 2007 Sep; 122(2):199-205. PubMed ID: 17706829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water soluble drug delivery systems based on a non-biological bioadhesive polymeric system.
    Cappello B; Del Nobile MA; La Rotonda MI; Mensitieri G; Miro A; Nicolais L
    Farmaco; 1994 Dec; 49(12):809-18. PubMed ID: 7893338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design.
    Duque MD; Kreidel RN; Taqueda ME; Baby AR; Kaneko TM; Velasco MV; Consiglieri VO
    Pharm Dev Technol; 2013; 18(5):1247-54. PubMed ID: 22670808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.
    Liu Q; Fassihi R
    J Pharm Pharmacol; 2009 Jul; 61(7):861-7. PubMed ID: 19589227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.